A status check on OV 3.0
Written by OMERS Ventures Senior Managing Partner, Michael Yang. Six months ago, I posted my initial thoughts on OV 3.0. Now that we’ve had some runtime in this new world order,… Read More »A status check on OV 3.0
Written by OMERS Ventures Senior Managing Partner, Michael Yang. Six months ago, I posted my initial thoughts on OV 3.0. Now that we’ve had some runtime in this new world order,… Read More »A status check on OV 3.0
19 April 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2023 Biodexa Pharmaceuticals PLC (NASDAQ: BDRX),… Read More »Preliminary Results for the Year Ended 31 December 2023
By Marissa Moore, CFA and Taku Murahwi While the interplay of factors that make a specific vertical more ready than others for AI-powered innovation is complex, we identified a few factors… Read More »What makes an industry well-suited for vertical AI?
Written by Marissa Moore and Taku Murahwi. Vertical software is naturally an area of intense business transformation, and dramatic, fundamental shifts. To keep on top of what industries and categories… Read More »Where we’re looking to invest in vertical B2B software & AI
Written by Dave Wechsler. The Insurtech category is starting to bounce back. Coming off investment lows of ’22 and ’23, there’s renewed interest from the VC community in Insurtechs… Read More »Optimizing your Insurtech for venture investment
By Marissa Moore, CFA and Taku Murahwi At this point, we all know AI is drastically changing many job functions, across many industries. But not all verticals are created equal — and… Read More »Mapping the impending impact of Vertical AI
Why Regular Cleaning is Essential Regular cleaning is essential for maintaining the performance and longevity of your computer system. Over time, dust, dirt, and debris can accumulate on the various… Read More »Keep Your Computer Sparkling Clean
A developer platform to solve the notification bell David Sacks · Follow Published in Craft Ventures · 3 min read · Feb 15, 2024 — Knock cofounders Chris Bell &… Read More »Why We Invested in Knock
Mike Marg · Follow Published in Craft Ventures · 7 min read · Feb 12, 2024 — By Mike Marg and Justin Reidy, Craft Ventures It’s been a little over… Read More »The AI Simple Stack
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option Closes acquisition of exclusive, worldwide license to Tolimidone, Phase… Read More »Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option